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Abstract Background Complex medication regimens
may adversely affect compliance and treatment outcomes.
Complexity can be assessed with the medication regimen
complexity index (MRCI), which has proved to be a valid,
reliable tool, with potential uses in both practice and
research. Objective To use the MRCI to assess medication
regimen complexity in institutionalized elderly people.
Setting Five nursing homes in mainland Portugal. Methods
A descriptive, cross-sectional study of institutionalized
elderly people (n = 415) was performed from March to
June 2009, including all inpatients aged 65 and over taking
at least one medication per day. Main outcome measure
Medication regimen complexity index. Results The mean
age of the sample was 83.9 years (±6.6 years), and 60.2 %
were women. The elderly patients were taking a large
number of drugs, with 76.6 % taking more than five
medications per day. The average medication regimen
complexity was 18.2 (±SD = 9.6), and was higher in the
females (p \ 0.001). The most decisive factors contribut-
ing to the complexity were the number of drugs and dosage
frequency. In regimens with the same number of medica-
tions, schedule was the most relevant factor in the final
score (r = 0.922), followed by pharmaceutical forms
(r = 0.768) and additional instructions (r = 0.742). Con-
clusion Medication regimen complexity proved to be high.
There is certainly potential for the pharmacist’s interven-
tion to reduce it as part as the medication review routine in
all the patients.
Keywords Drug therapy complexity  Elderly  MRCI 
Nursing homes  Portugal
Impact of findings on practice statements
• Regimen complexity assessment by clinicians and
pharmacists should be a high priority in the manage-
ment of institutionalized elderly patients.
• Nursing homes should consider conducting medication
reviews in order to reduce the complexity of older
patients’ drug regimens.
• Educational sessions for managers, pharmacists, clini-
cians and patient attendants working at nursing homes
would be of great value.
• MRCI could be an important tool in monitoring drug
therapy complexity at nursing homes in Portugal and
identifying the potential ways of reducing it.
Introduction
Demographic aging is a global phenomenon. The United
Nations estimates that elderly people currently account for
11 % of the total population (about 800 million), and an
exponential increase is expected up to 2050 (about 2 bil-
lion) [1].
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Portugal is among the most aging countries. According
to the United Nations (which considers everyone aged 60
or over to be elderly), 24 % of the Portuguese population
was elderly in 2011. The 2011 National Census data
(Statistics Portugal [2]) showed that there were about 129
elderly (C65 years) per 100 young people (\15 years),
representing 19 % of the total population [1–3].
The social transition that follows this phenomenon, at least
in more developed countries, often conditions the possibility
of aging in the family environment. Institutionalization of the
elderly is frequently driven by a lack of domestic and social
support and the admission in a care home is often the only way
to have access to care and services, especially health, that they
would otherwise not receive [4–6].
In most cases, aging is also synonymous with chronic
diseases and consequently polypharmacy. Old people are
the age group with highest consumption of medications.
Polypharmacy is associated with adverse reactions, greater
risk of hospitalization, poor adherence and unnecessary
costs for the patient [7–10].
A large number of medications and complicated
schedules or additional instructions can also contribute to
the patient’s increased difficulty or loss of interest in fol-
lowing treatment recommendations and therefore poor
clinical outcomes [11]. The results of several studies have
shown that adherence declines as medication regimen
complexity increases and this complexity is one of the
main root causes of patients’ non-compliance. It may also
result in medication errors—the more complex the regimen
is to follow, the easier it is for the patient to get it wrong.
Poor adherence and medication errors are a serious concern
for health practitioners. They often lead to higher use of
resources, owing to a reduction in effectiveness and
increased risk of therapeutic failure [12–14].
Medication regimen complexity is therefore a major
concern for patients with chronic diseases and their care-
givers. The complexity of a person’s medication regimen
depends on the characteristics of the pharmacotherapy,
such as the number of drugs consumed, their pharmaceu-
tical forms, schedules and doses and additional instructions
given by the physician. It can be measured with the med-
ication regimen complexity index (MRCI), originally val-
idated in English by George [15] and adapted to Portuguese
by Melchiors [16]. The MRCI has proved to be a valid,
reliable tool for quantifying medication regimen com-
plexity. It is, fast (5–10 min) with potential use in both
practice and research [15].
The MRCI is divided into three different sections, which
contribute to the final score based on the weight of the tasks
in the medication regimen. Section A covers pharmaceu-
tical forms, Section B frequencies and Section C additional
instructions. Each section has its own score and the final
complexity score is the sum of the section subtotals [15].
Older people in residential aged-care facilities have
many of the difficulties experienced by those in the com-
munity, but also encounter problems specific to that envi-
ronment. In nursing homes medication regimen complexity
and its problems arise not just from the medication taken
but also other factors, such as lack of training of staff
administering the medication, no pharmacovigilance and
no medication follow-up or reviews [15–17].
Stange [18] and Elliott [19] identified dosing frequency
as the simplification with the highest potential, especially
in inpatients, followed by the number of dose units and the
time of administration—Sections B and C of the MRCI.
Higher MRCI scores were associated with increased risk
of emergency department visits and hospitalization, even
after controlling for number of medications and case-mix
(demographics, comorbidity and clinical and functional
status) [20].
Simplification and greater attention to managing com-
plexity are potentially remedial factors for poor adherence
and medication errors, not only in community dwelling
elders, but also in institutionalized patients. However,
before remedial action can be taken, patients with complex
management regimens must be identified.
Aim of the study
The aim of this study was to assess the medication regimen
complexity of institutionalized elderly people, using the
MRCI to identify the type of action with the highest
potential for reducing complexity (according to the three
MRCI sections) and contribute to rational use of medica-
tion in this frailer population.
Method
This descriptive, cross-sectional study was conducted in
five nursing homes in mainland Portugal (Lisbon and A-
lentejo health regions) from March to June of 2009, and
included all inpatients aged 65 and over and taking at least
one medication a day (recorded in their medication sche-
dule). Selection of the nursing homes was based on the
following criteria: existence of written individual medica-
tion records, nursing and medical support and participation
agreement in the study.
Data collection was based on the MRCI, but also
included social, demographic and medication data.
The following factors were considered when scoring
complexity: the number of medications in the regimen;
their pharmaceutical forms (each different form represents
a unit); the number of doses per day (each dose represents a
unit); additional instructions (i.e. take with meals or break
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the tablet) (each instruction represents a unit). Additional
instructions also include some mechanical means needed to
administer medications, such as eye drops, inhalers or
injections.
The MRCI is an open-ended index, so there is no limit to
the total number of medications that can be included in it.
The minimum MRCI score for someone on medication is
1.5, which represents a single tablet or capsule taken once a
day as needed, while there is no established maximum as
the score increases with the number of medications.
Data were collected from the nursing home pharmacies
and the form was filled out in two stages. The first was a
transcription of each elderly patient’s medication profile
(approximately five minutes per individual) and the second
was use of the MRCI scale to evaluate medication regimen
complexity (approximately 10 min per individual profile).
Polypharmacy was considered six or more drugs [21].
Statistical analysis was performed with the SPSS (v19).
We considered a significance level of p \ 0.05 and a
confidence interval of 95 %. All study variables, including
baseline and outcome measures, were analyzed. For con-
tinuous measures, p values represented an overall F test of
the means. For categorical variables, a Chi square test was
performed to assess statistical significance.
In accordance with the Helsinki Declaration, informed
consent was obtained for collecting and processing infor-
mation and data confidentiality was ensured. Ethical
approval of the research was obtained from the institutions
involved. The results of the performed assessment were left
to the health professionals in charge of the medication
management of the involved Institutions, in order to allow
the implementation of interventions, aiming to reduce the
regimen complexity, when applicable.
Results
Patient profiles
Data was collected from 415 elderly patients. The sample’s
mean age was 83.9 years (±6.6 years), and 60.2 % were
women. Mean age by gender was 84.3 years (±6.2 years)
for women and 83.4 years (±7.1 years) for men (Table 1).
Medication profile
The sample (n = 415) took a total of 3,410 medications
and average consumption was 8.2 (±3.6) drugs per indi-
vidual per day, with a minimum of 1 and a maximum of 20.
Mean daily consumption was higher in females (8.9 ± 3.4
drugs) than in males at 7.2 drugs (±3.6) per day
(p \ 0.001). The majority of the sample (85.5 %) was
under polypharmacy.
Table 2 shows the sample’s drug consumption, phar-
maceutical forms and therapeutic groups.
Cardiovascular system (30.8 %), nervous system
(27.7 %) and metabolism and alimentary tract (16.4 %)
were the most common groups.
In the sample, 88.2 % (366/415) of the elderly were
taking at least one cardiovascular drug, 83.4 % (346/415)
at least one drug for the nervous system and 70.1 % (291/
415) at least one drug for the metabolism and alimentary
tract.
The top five active substances were low-dosage aspi-
rin—31.8 % (132/415), simvastatin—28.2 % (117/415),
Table 1 Socio demographic characterization of the sample
Variables Frequency (N = 415) %
Gender
Female 60.2
Male 39.8
Age group
65–74 years 9.6
75–84 years 40.5
C85 years 49.9
Table 2 Medication profile
Variables Frequency %
Daily consumption of drugs (n = 415)
(01–05 drugs) 23.4
(06–10 drugs) 51.8
(11–15 drugs) 21.2
(16–20 drugs) 3.6
Dosage forms (n = 3,410)
Tablets and capsules 84.5
Oral solutions 3.1
Powders and granules 2.9
Topicals (excl. Patches) 2.6
Patches 1.5
Eye drops and creams/ear drops 1.5
Nasal spray 0.2
Inhalers 2.6
Injections 0.9
Enemas and suppositories 0.2
Pharmacotherapeutic groups (n = 3,410)
Cardivascular system 30.8
Nervous system 27.7
Metabolism and alimentary tract 16.4
Blood 7.8
Respiratory system 4.3
Others 13.0
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furosemide—22.9 % (95/415), omeprazole—17.1 % (71/
415) and acetaminophen, 16.1 % (67/415).
Medication regimen complexity
The MRCI in the sample showed a mean of 18.2 (±9.6),
ranging from 2.0 to 53.5. The index was higher in the
women, with a mean of 19.6 (±9.1), and 16.1 (±9.9) in
men (p \ 0.001). Table 3 shows the sections of the med-
ication complexity index and mean values.
MRCI was higher as the number of drugs increased
(r = 0.879, CI 99 %, p \ 0.001). This was not a rule for
every single case, however, as some individuals had high
scores that were not related to a large number of drugs, but
rather to more complex tasks to be performed. There was
considerable variation in MRCI scores within regimens
with the same number of drugs (Fig. 1).
Of the factors that contributed to complexity, schedule
was the most relevant to the final score (r = 0.922), fol-
lowed by pharmaceutical form (r = 0.768), and additional
instructions (r = 0.742) (CI 99 % (p \ 0.001)).
In the elderly people receiving from 1 to 5 different
drugs, the total MRCI score was 6.6 (±2.9) while in those
receiving from 6 to 20 was 20.2 (±8.9) (CI 99 %
(p \ 0.001)).
Most of the medications (84.5 %) were taken in only
one form (tablet/capsule). About 99.3 % of the patients
were taking at least one tablet or capsule. The most com-
mon dosing frequency was one medication twice daily
(31.8 %).
Where additional instructions were concerned, 22.7 %
of the patients followed at least one, 22.2 % at least two
and 40 % three or more. The most frequent instructions
were to break or crush the tablets (27 %) and take or use
the medications at a specific time. The mean scores are
shown in Table 4.
Discussion
An aging population with a lack of family support leads to
more institutionalized elderly people [22]. Medication
management was found to rarely include in this population
a critical analysis or review of regimens and is usually
restricted to distribution.
The elderly population (living at home or in an institu-
tion) is particularly vulnerable to adverse drug reactions,
drug interactions and low compliance to chronic medica-
tion and it is essential to characterize drug therapy com-
plexity in order to do something to simplify it [23].
Validated tools can assess medication regimen com-
plexity. We chose the MRCI for this study, because it is a
comprehensive instrument that includes 65 items related
not only to prescription data (number of medications,
dosage forms), but also to dose frequency and instructions
on how to take the medication (e.g. break tablet) [15, 16].
The MRCI has been adapted to Portuguese for Brazil by
George [15] and Melchiors [16], but not for Portugal. From
the point of view of the authors this is not a limitation
because even if the language is slightly different, the tool is
to be used by health care professionals, not by patients, and
no problems related with the use of the instrument have
been reported during the study.
Medication profile
Mean consumption in the sample was 8.2 drugs per indi-
vidual per day. This high consumption is similar to results
found in other studies of elderly peoples’ pharmacotherapy
[24]. The polypharmacy observed in this study was also
similar to that found in the majority of studies performed in
this age group. Kaufman [25] in the USA found that 57 %
of women aged 65 and over took five or more drugs and
12 % took ten or more. In a study conducted in eight
Table 3 Medication regimen complexity index by sections (mean
scores)
MRCI profile
MRCI total score Mean (SD) Minimum Maximum
MRCI section A score 3.6 (3.1) 1.0 20.0
MRCI section B score 11.2 (5.4) 0.5 28.0
MRCI section C score 3.4 (3.0) 0 15.0
MRCI total score 18.2 (9.6) 2.0 53.5
Fig. 1 Scatterplot of medication regimen complexity index scores
according to the number of consumed drugs
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Table 4 Medication regimen complexity index by item (mean scores)
Section A
dosage forms
Mean Section B
Dosing frequency
Weight Mean
Oral Once daily 1 5.2
Capsules/tablets 1 Once daily prn 0.5 0
Gargles/mouthwashes 0 Twice daily 2 3.4
Gums/lozenges 0 Twice daily prn 1 0.1
Liquids 0.4 Three times daily 3 1.5
Powders/granules 0.5 Three times daily prn 1.5 0
Sublingual sprays/tabs 0 Four times daily 4 0.2
Topical Four times daily prn 2 0
Creams/gels/ointments 0.3 q 12 h 2.5 0.1
Dressings 0 q 12 h prn 1.5 0
Paints/solutions 0 q 8 h 3.5 0
Pastes 0 q 8 h prn 2 0
Patches 0.2 q 6 h 4.5 0
Sprays 0 q 6 h prn 2.5 0
Ear, eye and nose q 4 h 6.5 0
Ear drops/creams/ointments 0 q 4 h prn 3.5 0
Eye drops 0.3 q 2 h 12.5 0
Eye gels/ointments 0 q 2 h prn 6.5 0
Nasal drops/cream/ointment 0 prn/sos 0.5 0.2
Nasal spray 0 On alternate days or less frequently 2 0.5
Inhalation Oxygen prn 1 0
Oxygen \ 15 h 2 0
Accuhalers 0.1 Oxygen [ 15 h 3 0
Aerolizers 0.1 Total for Section B 11.2
Metered dose inhalers 0.2 Section C
Additional directions
Weight Mean
Nebuliser 0.1
Oxygen/concentrator 0.1
Turbuhalers 0.1
Other DPIs 0 Break or crush tablet 1 0.7
Others Dissolve tablet/powder 1 0.2
Dialysate 0 Multiple units at one time (e.g. 2 tabs, 2 puffs) 1 0.3
Enemas 0
Injections Variable dose
(e.g. 1–2 caps, 2–3 puffs)
1 0
Prefilled 0.1
Ampoules/vials 0.1 Take/use at specified time/s (e.g. mane, nocte, 8 AM) 1 1
Pessaries 0 Relation to food (e.g. pc, ac, with food) 1 0.3
Patient controlled analgesia 0 Take with specific fluid 1 0
Suppositories 0 Take/use as directed 2 0.4
Vaginal creams 0 Tapering/increasing dose 2 0
Total for Section A 3.6 Alternating dose (e.g. one mane and two nocte,
one/two on alternate days)
2 0.5
Total for Section C 3.4
Medication complexity index (Section A ? Section B ? Section C)
18.2
Int J Clin Pharm
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European countries, Fialova´ [26] observed that 51 % of
elderly people were taking six or more drugs a day. Sicras-
Mainar [27] found higher consumption of oral forms
(84.5 %).
Castellar [17] obtained similar results for medication
profiles. By therapeutic groups, he found that the medica-
tions taken most were for the cardiovascular system
(27.3 %), followed by the nervous system (21.6 %) and the
alimentary tract and metabolism (14.1 %) [17].
Similar results were also obtained by Muir [28], in
which the active substance that individually appeared most
often in medication record was, acetylsalicylic acid 100
and 150 mg, found in 31.8 % of cases.
Medication regimen complexity
Older people, especially women, are more prone to poly-
pharmacy due to multiple chronic conditions that they
usually suffer and their greater propensity for taking
medications. In the current study, however, only gender
contributed significantly to the complexity of therapeutic
schemes [15].
The average complexity index of the sample was 18.2.
This figure is different from the results found in other
published studies that used the same instrument: Oosthui-
zen [29] obtained a figure of 19.3 in an age range of
60–69 years, and Correr [30] found an average complexity
of 15.5 in individuals older than 30. In our study, the older
population taking a large number of medications may
explain the average complexity index figure. However, a
greater number of medications does not always mean a
higher complexity index. This confirms the index’s ability
to emphasize the different complexity of regimens with the
same number of drugs, and demonstrates that the MRCI
goes beyond the mere quantification of drugs [15, 28].
The correlation between the complexity index’s total
ratio and its three sections (A, B and C) in particular shows
direct proportionality. In other words, a higher complexity
index is the direct result of individual growth in each
section [15].
As the MRCI is an open-ended index, with no maximum
value, no articles or authors were found who tried to
establish a cut-off, a figure related to negative health out-
comes and the need to intervene. However, several studies
have investigated the positive impact of intervention aimed
at reducing the complexity of medication regimens when-
ever possible [18, 31].
Like Stange [18], the most relevant factors found for
complexity were schedule (section B of the MRCI-fre-
quency of doses), followed by pharmaceutical forms and
additional instructions. Here, specialized intervention by a
healthcare professional, particularly a pharmacist, may be
more effective in reducing it in a medication review [18].
Khalil [32] demonstrated the importance of the doctor-
pharmacist collaboration in the management of residents’
medications in aged care facilities from the point of view
of the patient safety.
The assessment of regimen complexity using the MRCI
may be an effective tool for professionals managing the
medication of the elderly in order to promote rational use
of drugs. In a study on the effect of medication reviews in
institutionalized elderly, Zermansky [33] demonstrated its
advantages, when performed by specialized professionals,
not only in terms of patient health outcomes, but also of
costs. However, the additional time, effort, and profes-
sional training needed to calculate it may decrease its use
and popularity [13]. In 2013 McDonald et al. [11] devel-
oped a tool that for automating calculation of the MRCI
score and accelerating evaluation of its potential.
Conclusion
The literature highlights medication complexity as a factor
likely to impact negatively on patient compliance and
ultimately treatment efficacy and safety, and should
therefore be considered as a particularly important aspect
in the elderly population.
This study evaluated medication complexity in institu-
tionalized male and female patients taking different med-
ications and patients with different underlying conditions.
Medication complexity evaluated by the MRCI index
was found to be high (average of 18.2), and higher in
females, suggesting the need for further intervention. It was
mainly related to the number of medications taken chron-
ically, and also to dose frequency.
Of the factors that contributed to complexity, schedule
was the most relevant to the final score, followed by
pharmaceutical forms and additional instructions, in which
a medication review by a healthcare professional may be
more effective in reducing it.
The MRCI showed good evidence of classifying regi-
men complexity better than a simple medication count, in
the studied population. It proved to have potential in the
routine to help reduce medication regimen complexity by
identifying factors that contribute to this complexity in
elderly care institutions, thereby promoting compliance and
avoiding medication errors.
Given the large body of evidence that regimen com-
plexity is an important predictor of treatment burden,
medication adherence and outcomes, more attention should
be devoted to this aspect.
Health care professionals and particularly pharmacists
should be trained to use the MRCI, in order to assess the
complexity of medication regimen of their older patients,
and try to found solutions to reduce it, whenever possible.
Int J Clin Pharm
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